Diarrhoea is a hallmark of intestinal inflammation. The mechanisms operating in acute inflammation of the intestine are well characterized and are related to regulatory changes induced by inflammatory mediators such as prostaglandins, cytokines or reactive oxygen species, along with leakage due to epithelial injury and changes in permeability. In chronic colitis, however, the mechanisms are less well known, but it is generally accepted that both secretory and absorptive processes are inhibited. These disturbances in ionic transport may be viewed as an adaptation to protracted inflammation of the intestine, since prolonged intense secretion may be physiologically unacceptable in the long term. Mechanistically, the changes in transport may be due to adjustments in the regulation of the different processes involved, to broader epithelial alterations or frank damage, or to modulation of the transportome in terms of expression. In the present review, we offer a summary of the existing evidence on the status of the transportome in chronic intestinal inflammation.
Intestinal inflammation and the enterocyte transportome Introduction
One of the classical symptoms of intestinal inflammation is diarrhoea, so much so that this term is used popularly as a synonym of 'colitis'. Acute colitis of any aetiology is associated with inhibition of ion (NaCl) absorption and increased Cl − and HCO 3 − secretion, resulting in water accumulation in the large bowel and diarrhoea. These episodes are relatively often and may be associated with bacterial or viral infections or parasitic infestations (e.g. Giardia), which typically are self-limiting or can be effectively controlled with medication. Conversely, chronic colitis is a more restricted phenomenon which has different causes, including ulcerative colitis and Crohn's disease [commonly referred to as IBD (inflammatory bowel disease)], collagenous colitis and malabsorption syndromes. As in acute cases, chronic colitis is typically accompanied by diarrhoea, but the mechanisms are somewhat different. For many years, it was assumed that diarrhoea was the logical consequence of the relative abundance of inflammatory mediators brought about by mucosal inflammation. Indeed, the vast majority of these mediators, such as prostaglandins, leukotrienes, TNFα (tumour necrosis factor α), IL (interleukin)-1β, histamine and reactive oxygen species, have well-documented prosecretory properties in vitro, and, in some cases, inhibition of NaCl absorption has also been noted [1] . However, the picture is more complex than this simple interpretation, since many studies have shown that the inflamed intestine has an inhibited response to secretagogues, including the mediators mentioned, but also a wide array of other unrelated stimuli [1] . Furthermore, basal ion secretion, as measured by a spontaneous short-circuit current (which in the colon represents mainly Cl − secretion), is frequently diminished as well, suggesting that attenuation of this important physiological function is ongoing as inflammation is prolonged.
There are fewer studies focusing on absorptive processes in this setting, probably for purely practical reasons. In the intestine, ionic secretion involves the serosal to mucosal movement of Cl − and HCO 3 − in an electrogenic fashion, i.e. one that is readily monitored by changes in electrical parameters. The standard technique applicable here (Ussing chamber and voltage clamping) has been available for decades and is both simple and straightforward. In contrast, the main absorptive processes in the intestine are electroneutral, because ions are transferred from one side of the membrane to the other by exchangers, i.e. Slc (solute carrier) 26a3 (also known as DRA, for 'down-regulated in adenoma'), Slc26a6, Slc9a2 [also known as NHE (Na + /H + exchanger) 2] and Slc9a3 (also known as NHE3). The Na + /H + and Cl − /HCO 3 − exchangers are themselves coupled in those cells that co-express them (which is not always the case [2] ). Hence these movements are 'electrically silent' and cannot be detected as changes in voltage, conductance or current. Classically, radioactive tracers have been used to 'mark' unidirectional fluxes at either side of the Ussing chamber, so that net transfer of ions could be calculated. Needless to say, this is a cumbersome and less flexible approach. Of note, there have been important technical advances here that take advantage of fluorescent probes to track changes in pH under different experimental conditions [3] . The picture that emerges from the limited evidence available clearly points to a decreased absorption status in the inflamed intestine, similar to the inhibition in secretory mechanisms. From a mechanistic point of view, however, the picture is less clear [1] .
Mechanisms of altered transport: the 'sick' enterocyte
A diminished physiological function may arise from a number of contributing factors. First, the epithelium, i.e. the layer of cells ultimately in charge of all transport in the intestine, may be damaged and less capable of performing its tasks. This may result from metabolic insufficiency, a lower number of enterocytes per surface unit, etc. Secondly, there may be a regulatory adaptation to the inflammatory conditions brought about by mediators or second messengers. Thirdly, the very molecules in charge of the movement of ions (i.e. the transportome) may be altered by changes in expression. Obviously, these possibilities are not mutually exclusive and may be interconnected. What is known about the mechanisms that account for the disturbances in intestinal transport in chronic inflammation? Let us focus first on the status of the mucosa and specifically on the epithelial layer. For a long time, it has been known that IBD is linked with increases in intestinal permeability, which appears to precede the onset of the inflammatory response (at least in clinical terms). In fact, augmented permeability has been documented in first-degree relatives of IBD patients without other signs of disease [4] . Increased leakiness is considered to facilitate the mucosal penetration of luminal antigens and/or microorganisms, thereby making the mucosa more vulnerable to inflammation. One of the main IBD models is based precisely on the disruption of the epithelial layer by dextran sulfate, suggesting that this is a relevant mechanism in vivo, but the degree of derangement is not really comparable. Permeability changes in IBD appear to be related to augmented tight junction permeability, including increased susceptibility to noxious factors in uninflamed areas [5] [6] [7] . Increased transcellular transport has also been reported.
On the other hand, epithelial cells may be themselves damaged by the inflammatory reaction and the ulcerated condition of the mucosa gives its name to one of the two main manifestations of IBD, i.e. ulcerative colitis. In addition to producing microlesions in the epithelial layer and causing a breach in its continuity, the enterocyte phenotype may change as a result of cellular stress and/or regulatory changes. For instance, we have described how epithelial cells may exhibit a change in the alkaline phosphatase isoform under these conditions, which may be involved in mucosal defence [8] . The occurrence of discontinuities in this barrier may conceivably favour fluid leakage to the lumen from the lamina propria, contributing to diarrhoea.
Mechanisms of altered transport: regulatory changes
Of course, the alterations in enterocytes just described are expected to result in changes in ionic transport that are difficult to reverse in the short term. However, a few studies have reported that some of these disturbances, namely inhibited secretion (measured as short-circuit current, I sc , in Ussing chambers), can be at least partly revoked in vitro in animal models of IBD. For instance, the iNOS (inducible nitric oxide synthase)-selective inhibitor L-NIL [L-N 6 -(1-iminoethyl)lysine] has been shown to reverse the reduced secretory response to IBMX (3-isobutylmethylxanthine) and electrical field stimulation, but not to carbachol (an agonist of muscarinic and nicotinic receptors), in experimental colitis [9] . Removal of the submucosa before mounting the mucosal sheets in Ussing chambers also reverses at least partly the defects in ionic secretion [10] . These changes are executed in a matter of minutes and therefore suggest that the changes in transport must be, at least in part, of regulatory nature.
Considering next the issue of regulatory changes, nitric oxide has been implicated by several groups. This mediator may interfere with cAMP-regulated secretion, including CFTR (cystic fibrosis transmembrane conductance regulator) trafficking, by inhibiting adenylate cyclase in a guanylate cyclase-independent fashion [11] . cAMP is reportedly low in enterocytes isolated from rats with experimental colitis and this is consistent with alterations in ionic secretion [10] . The AMPK (AMP-activated protein kinase) has been also implicated in these disturbances. AMPK was activated in parallel to the inflammatory response, and its pharmacological modulation was found to correlate with the defect in induced epithelial secretion [12] . Nitric oxide that originates in enteric glial cells may also elicit changes in the cholinergic regulation of transport in the inflamed intestine. It should be noted that there are conflicting studies on the role of nitric oxide and that this question therefore remains unsolved [1] . To the best of our knowledge, none of these studies has focused on alterations in absorption, and as a result we know nothing about specific regulatory changes of this type in the inflamed intestine.
Mechanisms of altered transport: changes in the transportome
In contrast with the above, the condition of the transportome has been studied by several groups both in humans and in experimental animal and cellular models. This is probably because measuring expression is again easier than evaluating function. A summary of the data available is shown in Table 1 . The Na + /K + ATPase is reportedly down-regulated in cellular models under the influence of IFNγ (interferon γ ), in experimental colitis, and in human IBD patients. One study found unchanged mRNA, but lower protein expression, suggesting that both transcriptional and post-transcriptional mechanisms may be operative in these conditions [13] . The Na + /K + ATPase is at the core of all ionic transport by OCTN1-2 ↓ expression in IBD [41, 47] AC ↓ expression by IFNγ [48] the enterocyte, as it generates the electrochemical gradient necessary for vectorial transport. Hence decreased secretion and absorption are both bound to occur if the function of this pump is compromised, as happens, for instance, by adding ouabain to Ussing chamber preparations of rat colon.
Ionic secretion is largely regulated physiologically at the level of the Cl − and HCO 3 − apical channel CFTR (Figure 1) . Modulators of ionic secretion in the intestine either activate this channel directly or require that it is activated by other permissive influences, most notably prostaglandins [1] . In addition, CFTR is a co-regulator of the absorptive transporters NHE3 and DRA, so that it affects both secretory and absorptive processes. Hence this is an important element of the transportome. However, the available studies show conflicting data in this regard, ranging from down-regulation to an increased expression (Table 1) . If we look at NHE3 and DRA, the studies indicate either decreased or unaffected expression. The occurrence of effects may be dependent on the severity of inflammation, as documented in one study on NHE3 [26] . Of course, these changes would reinforce the impact on absorption of the lowered expression of the Na + /K + ATPase. Cl − ions that exit the cell towards the lumen via CFTR are provided by the facilitative action of the basolateral transporter NKCC1 (Na + -K + -Cl − co-transporter 1), which co-transports Na + and K + as well. There is comparatively little information on this essential part of Cl − secretion, but it appears also to be unaffected or downregulated.
In the distal segment of the colon, Na + is absorbed electrogenically via the ENaC (epithelial Na + channel), which is a trimer composed of α, β and γ subunits. ENaC is finely regulated depending on the physiological needs for Na + of the body via the action of circulating aldosterone. The β and γ subunits of ENaC (which are the regulated ones) have been found to be expressed at low levels in experimental colitis and in IBD. In addition, pro-inflammatory cytokines (TNFα, IFNγ and IL-1β) decrease the expression of the β/γ subunits [32, 35, 38] . Even the response to aldosterone is severely impaired. In fact, cytokines can also elicit effects on permeability and transport in vitro which, to a certain extent, mimic the changes observed in intestinal inflammation in vivo. NHE3 and NHE2 are acutely down-regulated by IFNγ in vivo and in vitro, and NHE3 activity can be downregulated by nitric oxide through the cGMP pathway in Caco-2 cells [34] . Interestingly, IFNγ is increased in NHE3-knockout mice and is thought to play a role in physiological compensation in this model, counteracting diarrhoea [14] . Similarly, TNFα and/or IFNγ reduce Na + /K + ATPase and NKCC1 expression in cellular models. The implication is that cytokines, nitric oxide and possibly other mediators induce substantial changes in the transportome as part of the inflammatory expression programme. Table 1 also shows data available on other less well studied elements of the transportome which undoubtedly deserve further attention. Because of limitations of space, these will not be discussed further here.
Conclusions
Insofar as disturbances in transport are due to changes in the transportome, reversibility can be achieved only in the long term, whereas regulatory modulation is clearly more feasible to short-term changes. Many of these transporters are regulated at different levels, including turnover number, endosomal recycling and expression.
In strictly physiological terms, the inhibition of secretion in chronic inflammation (as opposed to acute episodes, as explained above) makes sense because the continued effects of inflammatory mediators would probably result in excessive losses of water and electrolytes that are not counterbalanced by any advantages, possibly related to extrusion of intestinal parasites or micro-organisms from an evolutionary point of view. 
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